Research programme: antibacterials - Kosan Bioscience
Alternative Names: KOS-1835; Macrolide antibacterials - Kosan BioscienceLatest Information Update: 13 Nov 2007
At a glance
- Originator Kosan Biosciences
- Class Ketolides; Macrolides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 13 Nov 2007 KOS 1835 is available for partnering (http://www.kosan.com)
- 14 Aug 2003 Preclinical trials in Bacterial infections in USA (unspecified route)